Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAP2K4 Antikörper (pSer257)

Der Kaninchen Polyklonal anti-MAP2K4 Antikörper wird verwendet zum Nachweis von MAP2K4 in Proben von Human, Maus und Ratte. Er wurde validiert für IHC, ELISA und IF.
Produktnummer ABIN8123007
276,00 €
Zzgl. Versandkosten 20,00 € und MwSt
50 μL
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für MAP2K4 Antikörper (pSer257) (ABIN8123007)

Target

Alle MAP2K4 Antikörper anzeigen
MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4))

Reaktivität

  • 178
  • 94
  • 74
  • 9
  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 171
  • 11
Kaninchen

Klonalität

  • 171
  • 12
Polyklonal

Konjugat

  • 91
  • 15
  • 11
  • 9
  • 6
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser MAP2K4 Antikörper ist unkonjugiert

Applikation

  • 110
  • 72
  • 70
  • 26
  • 18
  • 16
  • 15
  • 11
  • 6
  • 5
  • 4
  • 3
  • 2
Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
  • Bindungsspezifität

    • 40
    • 24
    • 18
    • 12
    • 12
    • 10
    • 9
    • 8
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 223-272, pSer257

    Verwendungszweck

    MEK-4 (phospho Ser257) Antibody

    Spezifität

    Phospho-MEK-4 (S257) Polyclonal Antibody detects endogenous levels of MEK-4 protein only when phosphorylated at S257.

    Aufreinigung

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Immunogen

    The antiserum was produced against synthesized peptide derived from human SEK1/MKK4/JNKK1 around the phosphorylation site of Ser257. AA range:223-272

    Isotyp

    IgG
  • Applikationshinweise

    IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C/1 year

    Haltbarkeit

    12 months
  • Target

    MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4))

    Andere Bezeichnung

    MEK-4

    Hintergrund

    Synonyms: MAP2K4, JNKK1, MEK4, MKK4, PRKMK4, SEK1, SERK1, SKK1, Dual specificity mitogen-activated protein kinase kinase 4, MAP kinase kinase 4, MAPKK 4, JNK-activating kinase 1, MAPK/ERK kinase 4, MEK 4, SAPK/ERK kinase 1, SEK1, Stress-activated pro

    Background: This gene encodes a member of the mitogen-activated protein kinase (MAPK) family. Members of this family act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. They form a three-tiered signaling module composed of MAPKKKs, MAPKKs, and MAPKs. This protein is phosphorylated at serine and threonine residues by MAPKKKs and subsequently phosphorylates downstream MAPK targets at threonine and tyrosine residues. A similar protein in mouse has been reported to play a role in liver organogenesis. A pseudogene of this gene is located on the long arm of chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013],

    Gene Name: MAP2K4

    Protein Name: Dual specificity mitogen-activated protein kinase kinase 4

    Gen-ID

    6416

    UniProt

    P45985

    Pathways

    MAPK Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, BCR Signaling
Sie sind hier:
Chat with us!